InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Loewen Andrea. Officer active across 1 company, notably Reata Pharmaceuticals INC. Cumulatively, 6 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €1.1m. History available since 3 January 2023. The latest transaction was disclosed on 14 September 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Loewen Andrea is SVP, Global Regulatory Affairs at Reata Pharmaceuticals INC (XNAS). She has 6 filings in total, and across the 6 sampled recent filings between 2023-01-04 and 2023-09-26, sales total EUR 1065574 and the modal transaction nature is Sale.